Amneal Pharmaceuticals Hiring Analytical Development Executive / Senior Executive – M Pharm, MSc, B Pharm

Amneal Pharmaceuticals Hiring Analytical Development Executive / Senior Executive – M Pharm, MSc, B Pharm

Join Amneal Pharmaceuticals – A Global Leader in Pharmaceutical Innovation

Amneal Pharmaceuticals is currently hiring Analytical Development Executive / Senior Executive for its Inhalation – MDI/DPI division in Ahmedabad, Gujarat. If you are a highly skilled pharma professional with a background in M Pharm, MSc, or B Pharm, this opportunity is for you!

Job Role & Responsibilities

The selected candidate will be responsible for key analytical method development and CMC activities for inhalation dosage forms. The primary responsibilities include:

• Analytical Activities: Development, scale-up support, method validation, and transfer.
• Quality Control & Compliance: Conducting release, stability, and drug product characterization.
• Regulatory Studies: Performing E&L Study, In-vitro study, and routine analysis of inhalation dosage forms.
• Testing & Analysis: Carrying out tests such as assay, related compounds, APSD, DDU, and particulate matter analysis.

Qualifications & Experience

• Educational Requirement: M Pharm, MSc, or B Pharm.
• Experience Required: Candidates with relevant experience in Analytical Development for inhalation dosage forms (MDI/DPI) will be preferred.
• Location: Ahmedabad, Gujarat, India.

About Amneal Pharmaceuticals

Amneal Pharmaceuticals is a renowned multinational pharmaceutical company committed to developing and manufacturing high-quality, affordable medicines. With a strong presence in various therapeutic areas, Amneal provides professionals with an excellent platform to grow their careers in the pharmaceutical industry.

How to Apply?

Interested candidates can apply directly through the official career page of Amneal Pharmaceuticals. Don’t miss this opportunity to advance your career in analytical development!

🔗 Apply Here: Amneal Pharmaceuticals Careers

📅 Application Deadline: February 28, 2025